Not applicableStudy completedNCT05360706What this trial is testingStudy of AAV5-hFIX in Severe or Moderately Severe Haemophilia BWho this might be right forHemophilia B CSL Behring 9
Not applicableLooking for participantsNCT03016806What this trial is testingUmbilical Cord Blood Transplantation From Unrelated DonorsWho this might be right forAcute LeukemiaImmune Deficiency DisorderCongenital Hematological Disorder+7 more University of Rochester 30
Testing effectiveness (Phase 2)Study completedNCT00944684What this trial is testingHigh Dose Ribavirin in the Treatment of Chronic Hepatitis CWho this might be right forChronic Hepatitis C University of Bern 32
Early research (Phase 1)Study completedNCT02594384What this trial is testingA Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma, Non-Hodgkin; Leukemia, Chronic Lymphocytic OrphAI Therapeutics 62
Testing effectiveness (Phase 2)Study completedNCT01237249What this trial is testingStudy of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With Revlimid/Low Dose DexamethasoneWho this might be right forMultiple Myeloma PETHEMA Foundation 250
Testing effectiveness (Phase 2)Study completedNCT00916058What this trial is testingConditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Weill Medical College of Cornell University 57
Large-scale testing (Phase 3)Looking for participantsNCT07297329What this trial is testingEvaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for TransplantWho this might be right forMultiple Myeloma (MM) Sinocelltech Ltd. 292
Early research (Phase 1)Not Yet RecruitingNCT07841002What this trial is testingCLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forRelapsed/Refractory Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia (AML) Liping Dou 12
Testing effectiveness (Phase 2)Ended earlyNCT00589602What this trial is testingT-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more The Cleveland Clinic 13
Early research (Phase 1)Ended earlyNCT01644253What this trial is testingPhase 1b Safety and Efficacy Study of TRU-016Who this might be right forChronic Lymphocytic LeukemiaPeripheral T-cell Lymphoma Aptevo Therapeutics 87
Testing effectiveness (Phase 2)Study completedNCT02302495What this trial is testingStudy of Carfilzomib Weekly Plus Melphalan and Prednisone in Untreated Symptomatic Elderly Multiple MyelomaWho this might be right forMultiple Myeloma University Hospital, Lille 32
Testing effectiveness (Phase 2)Study completedNCT01295307What this trial is testingClofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia Technische Universität Dresden 86
Early research (Phase 1)Ended earlyNCT00928200What this trial is testingErwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)Who this might be right forRelapsed Acute Lymphoblastic LeukemiaAllergy to PEG e.Coli AsparaginaseAllergy to Native e.Coli Asparaginase Therapeutic Advances in Childhood Leukemia Consortium 1
Testing effectiveness (Phase 2)Study completedNCT00066092What this trial is testingPegfilgrastim PBPC Mobilization StudyWho this might be right forLymphomaHodgkin's LymphomaNon-Hodgkin's Lymphoma+2 more Amgen 41
Not applicableUnknownNCT05983536What this trial is testingThe Evaluation of Anti-interference Ability and Clinical Specificity of HIV Ag +Ab Assay Kit (Sysmex)Who this might be right forHIV SeropositivityCancerBlood Disease Qianfoshan Hospital 1,200
Testing effectiveness (Phase 2)Study completedNCT00045136What this trial is testingChemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Poniard Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01580410What this trial is testingSurgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the AppendixWho this might be right forCarcinoma of the AppendixPrimary Peritoneal Cavity Cancer Wake Forest University Health Sciences 136
Not applicableStudy completedNCT02133560What this trial is testingUse of Mobile Technology for Intensive Training in Medication ManagementWho this might be right forSickle Cell DiseaseThalassemia Duke University 46
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07299123What this trial is testingPhase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAAWho this might be right forSevere Aplastic Anemia (SAA)Severe Aplastic Anemia, RefractorySevere Aplastic Anemia Chinese PLA General Hospital 40
Not applicableNot Yet RecruitingNCT06660459What this trial is testingPattern of Menorrhagic Female Attending the Hematology Unit in Assuit University Children HospitalWho this might be right forMenorrhagia Assiut University 50